Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News aTyr Pharma Inc ATYR

Healthcare Biotechnology
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause... see more

Recent & Breaking News (NDAQ:ATYR)

StockCall Study on Life Technologies, Quest Diagnostics, DaVita, and Universal Health Services

PR Newswire March 14, 2013

The Real Story Behind LIFE, HEK, SU and DG

Marketwired March 13, 2013

New Assays, Enhanced Solutions Drive Momentum - Research Report on Quest Diagnostics, Life Technologies, LabCorp, Health Net, and CombiMatrix

PR Newswire March 13, 2013

Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University

PR Newswire March 4, 2013

Life Technologies & IMEGEN Develop Fast and Accurate Full Solution Horse DNA Test for Meat Products

PR Newswire March 1, 2013

Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings

PR Newswire February 25, 2013

Ion Semiconductor Sequencing Data Presentations at AGBT Demonstrate More than >1,000-fold Throughput Scaling in First Two Years on the Market

PR Newswire February 22, 2013

Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers

PR Newswire February 21, 2013

Turn Timing Into Profits With GOOG, VOD, BA and LIFE

Marketwired February 21, 2013

Free Research Report on Life Technologies Corporation, TripAdvisor, Inc., Nexstar Broadcasting Group, Inc., Regeneron Pharmaceuticals, Inc. and Coinstar, Inc.

Marketwired February 19, 2013

CollabRx Reports Q3 Fiscal Year 2013 Financial Results

Troy Schwensen February 12, 2013

Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits

PR Newswire February 11, 2013

Life Technologies Announces Fourth Quarter and Fiscal 2012 Results

PR Newswire February 4, 2013

Life Technologies Establishes International Influenza Network

PR Newswire January 29, 2013

Life Technologies to Present at Leerink Swann Global Healthcare Conference

PR Newswire January 25, 2013

Life Technologies Named #33 among Global 100 Most Sustainable Corporations

PR Newswire January 23, 2013

Free Research Reports on FHN, GEO, LIFE and ODP Issued by the Bedford Report

Marketwired January 21, 2013

Life Technologies to Report Fourth Quarter and Fiscal Year 2012 on Feb. 4

PR Newswire January 17, 2013

ACAS, LIFE, RMD and SCI Freshly Hit a New 52-Week High

Marketwired December 21, 2012